Although Akt is regarded as a downstream factor of the c‐Met pathway (Peters and Adjei, 2012), co‐activation of Akt and c‐Met triggers in the progression of HCC (Hu et al., 2016). This evidence concerns the gene MET and hepatocellular carcinoma.